Tag: Pep

According to the World Health Organization (WHO), antiretroviral therapy (ART) is crucial for managing HIV, and a core component of this strategy includes once-daily fixed-dose combinations. Reydin tablets are a triple-combination antiretroviral medication used to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults.

While a standard course of post-exposure prophylaxis (PEP) requires taking medication for a full 28 days, experts estimate that the active drugs are out of your system within 24 to 48 hours after the final dose. This guide explains the science behind **how long does PEP stay in your system** and the pharmacological factors that influence its clearance.

PEP must be initiated within 72 hours of potential HIV exposure, but modern guidelines confirm that tenofovir alone is not enough for PEP, and recommend combination therapy for post-exposure prophylaxis. This is a critical development in preventing HIV infection after exposure.

According to the World Health Organization (WHO) guidelines, combinations like Luvigen are recommended as first-line treatment for HIV infection. The drug Luvigen is a potent antiretroviral medication used to manage and control HIV (human immunodeficiency virus) in adults and certain pediatric patients.

First approved by the FDA in 2007, Isentress was the pioneering integrase inhibitor developed to treat HIV-1 infection. The medication, also known by its generic name raltegravir, is a crucial part of combination antiretroviral therapy (ART) and is used for both treatment-naive and treatment-experienced patients.